DrugPatentWatch Database Preview
Biologic Drugs With Dosage Form: INJECTABLE; IV (INFUSION)
» See Plans and Pricing
Details for Dosage Type: INJECTABLE; IV (INFUSION)
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | Start Trial | Momenta Pharmaceuticals, Inc. (Cambridge, MA) | 2029-01-22 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | Start Trial | University of Miami (Miami, FL) | 2030-10-19 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | Start Trial | OXFORD UNIVERSITY INNOVATION LIMITED (Oxford, GB) | 2034-01-13 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | Start Trial | ORBSEN THERAPEUTICS LIMITED (Galway, IE) | 2035-03-20 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | Start Trial | DMNOMORE (London, GB) | 2039-04-18 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
